Santarus
A specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists.
Employees
Enterprise value
$2.6b
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
$2.6b Valuation: $2.6b | Acquisition | ||
| Total Funding | 000k | ||
Fog City Capital(exited)
St. Paul Venture Capital(exited)
Windamere Venture Partners(exited)
Domain Associates(exited)
Advent Venture Partners(exited)
EQT Life Sciences(exited)
CDIB Capital Group(exited)
New England Partners(exited)
JP Morgan(exited)
Red Abbey Venture Partners(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads